Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000214384

Medchemexpress LLC Sri-011381 | 1629138-41-5 | MFCD01475985 | 99.6% | 329.48 g/mol | C20H31N3O | 50 MG
SDP

Catalog No. 5000214384
Encompass_Preferred

SRI-011381 is a small-molecule agonist of the TGF-β/Smad signaling pathway with reported neuroprotective effects. It is provided as a research-use chemical in powder and solution formats for in vitro and in vivo studies.

  • Orally active TGF-β/Smad signaling agonist
  • Reported neuroprotective effects in preclinical studies
  • Molecular formula C20H31N3O; molecular weight 329.48 g/mol
  • CAS number 1629138-41-5
  • High purity (~99.6%)
  • Available as dry powder and as 10 mM solution in DMSO
  • Store at 4°C protected from light; in solvent store at -80°C (6 months) or -20°C (1 month)

Catalog No. 50-002-14384 Supplier Medchemexpress LLC Supplier No. HY10034750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SRI-011381 is a small-molecule agonist of the TGF-β/Smad signaling pathway with reported neuroprotective effects. It is provided as a research-use chemical in powder and solution formats for in vitro and in vivo studies.

  • Orally active TGF-β/Smad signaling agonist
  • Reported neuroprotective effects in preclinical studies
  • Molecular formula C20H31N3O; molecular weight 329.48 g/mol
  • CAS number 1629138-41-5
  • High purity (~99.6%)
  • Available as dry powder and as 10 mM solution in DMSO
  • Store at 4°C protected from light; in solvent store at -80°C (6 months) or -20°C (1 month)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.